LASSIE GENTLE DIABETES CARE
LIVE

Serial Number

79314138

Owner

BOYDSENSE

Attorney

Nicholas D. Wells

Filing Date

Mar 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LASSIE GENTLE DIABETES CARE Trademark

Serial Number: 79314138 • Registration: 6854543

LASSIE GENTLE DIABETES CARE is a trademark filed by BOYDSENSE on March 22, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BOYDSENSE (3 trademarks)

Immeuble Le Colombus,

Entity Type: 34

Trademark Details

Filing Date

March 22, 2021

Registration Date

September 27, 2022

Published for Opposition

July 12, 2022

Goods & Services

Measuring apparatus and instruments for measuring gas concentration; gas sensors and apparatus for measuring volatile organic compounds; dowloadable software for use in data management for medical use; downloadable software for medical use for assisting users with the provided measuring apparatus and instruments; downloadable software for medical monitoring, management and organization of patient data; downloadable software for medical monitoring, managing and organization of patient data; embedded software for a portable breath-detection apparatus used for detecting diabetes and blood sugar levels in individuals; downloadable software and applications for mobile telephones, tablet computers and other mobile electronic devices, in the field of prevention, management and treatment of diabetes for management and organization of patient data

Sensor for use in medical diagnosis to gather human biometric data; detection apparatus in the nature of sensors and alarms for medical use for patient monitoring; control measurement apparatus for medical use, namely, control unit using breath as a fluid to estimate blood sugar values; mobile physiological monitoring apparatus and analysis apparatus for medical use, namely, medical diagnostic instruments for the analysis of body fluid; blood glucose monitoring system; glucose-level monitoring devices for medical purposes; apparatus for analysis of substances in gases for medical use in the nature of a gas sensor for medical use; apparatus for analysis of substances for medical use, namely, organic compounds and biomarkers, namely, body composition analyzers for medical purposes; analytical devices for medical use, for breath analysis; analytical devices for medical use, for breath analysis to estimate blood sugar values; mobile monitoring apparatus and apparatus for analysis for medical use, for breath analysis to estimate blood sugar values

Design and development of software, downloadable software and downloadable applications for mobile telephones, tablet computers and other mobile electronic devices in the field of prevention, management and treatment of diabetes; electronic storage and back-up of information and data in the field of prevention, management and treatment of diabetes; design of mobile applications for individuals to record, track and generate reports regarding the status, treatment and management of diabetes; provision of scientific research information relating to diabetes via downloadable applications for mobile telephones, tablet computers and other mobile electronic devices

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 14, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 23, 2023 FICS
FINAL DISPOSITION PROCESSED
Jan 23, 2023 FIMP
NOTIFICATION PROCESSED BY IB
Dec 28, 2022 GPNX
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 27, 2022 FICR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 3, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 3, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 3, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 3, 2022 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 29, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 29, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 11, 2022 TROA
REFUSAL PROCESSED BY IB
Dec 26, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 6, 2021 RFCS
REFUSAL PROCESSED BY MPU
Dec 6, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 4, 2021 RFCR
NON-FINAL ACTION WRITTEN
Nov 3, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 2, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 28, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 25, 2021 REPR